|
Summary Information: Larimar Therapeutics Inc. Common Stock NASDAQ:LRMR |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Larimar Therapeutics, Inc., is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company's lead compound, CTI-1601, is currently being evaluated in a Phase 1 clinical program in the U.S. as a potential treatment for FA. Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.
__The following are links to various summary and news pages for __Larimar Therapeutics Inc. Common Stock [ LRMR ]. __Note: Some Links might not have information for the company. |
|